Novavax Inc. Stock Slips 3.8%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. slipped 3.8% to $9.23 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.8% to 25,981.57 and Dow Jones Industrial Average falling 0.6% to 52,093.11.

The stock's fall snapped a two-day winning streak.

Novavax Inc. closed 22.9% short of its 52-week high of $11.97, which the company reached on February 26th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.3% to $267.20, Pfizer Inc. fell 0.6% to $27.55, and Merck & Co. Inc. fell 0.15% to $143.79.

Trading volume totaled 3.3 million, compared to the 50-day average of 4.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 15, 2026 16:35 ET (20:35 GMT)